Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography.
Kuroda M, Shinke T, Sakaguchi K, Otake H, Takaya T, Hirota Y, Osue T, Kinutani H, Konishi A, Takahashi H, Terashita D, Uzu K, Hirata K. Kuroda M, et al. Among authors: uzu k. Cardiovasc Diabetol. 2015 Jun 11;14:78. doi: 10.1186/s12933-015-0236-x. Cardiovasc Diabetol. 2015. PMID: 26062762 Free PMC article.
Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography.
Kuroda M, Shinke T, Otake H, Sugiyama D, Takaya T, Takahashi H, Terashita D, Uzu K, Tahara N, Kashiwagi D, Kuroda K, Shinkura Y, Nagasawa Y, Sakaguchi K, Hirota Y, Ogawa W, Hirata K. Kuroda M, et al. Among authors: uzu k. Cardiovasc Diabetol. 2016 May 21;15:79. doi: 10.1186/s12933-016-0395-4. Cardiovasc Diabetol. 2016. PMID: 27208906 Free PMC article.
Morphological and pharmacological determinants of peri-procedural myocardial infarction following elective stent implantation: Optical coherence tomography sub-analysis of the PRASFIT-Elective study.
Uzu K, Shinke T, Otake H, Takaya T, Osue T, Iwasaki M, Kinutani H, Konishi A, Kuroda M, Takahashi H, Terashita D, Hirata KI, Saito S, Nakamura M, Shite J, Akasaka T. Uzu K, et al. J Cardiol. 2017 Dec;70(6):545-552. doi: 10.1016/j.jjcc.2017.05.002. Epub 2017 Jun 12. J Cardiol. 2017. PMID: 28619235 Free article. Clinical Trial.
The impact of serum trans fatty acids concentration on plaque vulnerability in patients with coronary artery disease: Assessment via optical coherence tomography.
Nagasawa Y, Shinke T, Toh R, Ishida T, Otake H, Takaya T, Sugiyama D, Toba T, Kuroda M, Takahashi H, Terashita D, Tahara N, Shinkura Y, Uzu K, Kashiwagi D, Kuroda K, Nagano Y, Yamamoto H, Yanaka K, Tsukiyama Y, Hirata KI. Nagasawa Y, et al. Among authors: uzu k. Atherosclerosis. 2017 Oct;265:312-317. doi: 10.1016/j.atherosclerosis.2017.06.922. Epub 2017 Jun 28. Atherosclerosis. 2017. PMID: 28697847 Free article.
Impact of CD14++CD16+ monocytes on coronary plaque vulnerability assessed by optical coherence tomography in coronary artery disease patients.
Yamamoto H, Yoshida N, Shinke T, Otake H, Kuroda M, Sakaguchi K, Hirota Y, Toba T, Takahashi H, Terashita D, Uzu K, Tahara N, Shinkura Y, Kuroda K, Nagasawa Y, Nagano Y, Tsukiyama Y, Yanaka KI, Emoto T, Sasaki N, Yamashita T, Ogawa W, Hirata KI. Yamamoto H, et al. Among authors: uzu k. Atherosclerosis. 2018 Feb;269:245-251. doi: 10.1016/j.atherosclerosis.2018.01.010. Epub 2018 Jan 17. Atherosclerosis. 2018. PMID: 29407600
Data on impact of monocytes and glucose fluctuation on plaque vulnerability in patients with coronary artery disease.
Yamamoto H, Yoshida N, Shinke T, Otake H, Kuroda M, Sakaguchi K, Hirota Y, Toba T, Takahashi H, Terashita D, Uzu K, Tahara N, Shinkura Y, Kuroda K, Nagasawa Y, Nagano Y, Tsukiyama Y, Yanaka KI, Emoto T, Sasaki N, Yamashita T, Ogawa W, Hirata KI. Yamamoto H, et al. Among authors: uzu k. Data Brief. 2018 Mar 10;18:172-175. doi: 10.1016/j.dib.2018.03.022. eCollection 2018 Jun. Data Brief. 2018. PMID: 29900190 Free PMC article.
Peri-strut low-intensity area assessed by midterm follow-up optical coherence tomography may predict target lesion revascularisation after everolimus-eluting stent implantation.
Kuroda K, Otake H, Shinke T, Toba T, Kuroda M, Takahashi H, Terashita D, Uzu K, Kashiwagi D, Nagasawa Y, Nagano Y, Hirata KI. Kuroda K, et al. Among authors: uzu k. EuroIntervention. 2019 Apr 20;14(17):1751-1759. doi: 10.4244/EIJ-D-17-01134. EuroIntervention. 2019. PMID: 29957594 Free article.
33 results